WS 03 - Bridging the Valley of Death

Although infectious diseases remain a major health threat, the pipeline for novel intervention measures has come to a standstill. The situation has been further worsened by the profound increase of antimicrobial resistant pathogens and increasing occurrence of outbreaks with pandemic risk.
Hence, better vaccines, drugs and diagnostics are urgently needed. This is particularly true for poverty-related diseases (PRDs) including the Big Three – tuberculosis, HIV/AIDS and malaria – and neglected diseases. It has become obvious that public and private funded institutions need to form partnerships to accelerate this process.
This workshop will discuss general strategies for, and more specific examples, of the clinical development of novel intervention measures and their optimisation to key populations, aimed at accomplishing this goal with a particular focus on PRDs.